The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I-II study to evaluate safety and efficacy of the combination of niraparib plus cabozantinib in patients with advanced kidney/urothelial carcinoma.
 
Albert Font Pous
Consulting or Advisory Role - Janssen; Roche; Sanofi
 
Miguel Angel Climent Duran
Honoraria - Bristol-Myers Squibb; Eisai; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; msd; Pfizer; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
 
Ignacio Duran
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Novartis; Pharmacyclics; Roche/Genentech; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca Spain (Inst); Janssen Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Roche/Genentech
 
Begona Mellado
Consulting or Advisory Role - Astellas Medivation; Astellas Oncology; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Ipsen; Janssen; Novartis; Novartis; Pfizer; Roche; Sanofi
Research Funding - Roche
Travel, Accommodations, Expenses - Janssen; Pfizer
 
Jesus Paramio
Research Funding - Pfizer; Tesaro
Travel, Accommodations, Expenses - Janssen
 
Francisco X. Real
No Relationships to Disclose
 
Jose Luis Ramirez
No Relationships to Disclose
 
Juan Luis Sanz
No Relationships to Disclose
 
Daniel E. Castellano
No Relationships to Disclose